Brief: Abbisko Cayman Says Unit Obtained IND Approval For Absk061 From NMPA
03/03/2022 01:11
March 3 (Reuters) - Abbisko Cayman Ltd 2256.HK :
* UNIT OBTAINED IND APPROVAL FOR ABSK061 FROM NMPA
Source text for Eikon: ID:nHKS3rX7Xv
Further company coverage: 2256.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly